SAT0485 Safety Profile of the IL-1 Receptor Antagonist Kineret® (Anakinra) in a Long-Term Outcome Study in Patients with Severe Cryopyrin-Associated Periodic Syndromes (Caps)
2013 ◽
Vol 72
(Suppl 3)
◽
pp. A745.3-A746
Keyword(s):
Keyword(s):
2011 ◽
Vol 19
(10)
◽
pp. 1729-1734
◽
2000 ◽
Vol 25
(5)
◽
pp. 461-464
◽